Related Experiment Video
Updated: Mar 17, 2026

06:35
Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
1.7K
Adipocyte nuclei captured from VAT and SAT.
Suresh Ambati1, Ping Yu1, Elizabeth C McKinney1
1Department of Genetics, University of Georgia, Athens, GA USA.
BMC Obesity
|July 28, 2016
Summary
The MA-INTACT mouse model allows for the isolation of mature adipocyte nuclei from visceral and subcutaneous adipose tissue. This facilitates the study of epigenome reprogramming in obesity and related diseases.
Area of Science:
- Epigenetics
- Adipose Biology
- Obesity Research
Background:
- Obesity-related diseases stem from epigenome changes in tissues like visceral and subcutaneous adipose tissue (VAT and SAT).
- Understanding chromatin remodeling in mature adipocytes is challenging due to isolation difficulties.
Purpose of the Study:
- To develop a method for cell-type specific analysis of mature adipocyte nuclei.
- To investigate the epigenome of mature adipocytes in VAT and SAT.
Main Methods:
- Construction of MA-INTACT (Mature Adipocyte-Isolation of Nuclei TAgged in specific Cell Types) mice.
- Utilizing the adiponectin promoter to tag mature adipocyte nuclei with a reporter protein (SUN1mRFP1Flag).
- Immuno-capture of mature adipocyte nuclei from VAT and SAT.
Main Results:
- MA-INTACT mice efficiently isolated mature adipocyte nuclei (MVA and MSA) from VAT and SAT.
- Isolated nuclei showed high expression of adipocyte-specific transcripts and distinct profiles of leukocyte/endothelial markers.
- Differential expression of chromatin remodelers and thermogenic markers (PRDM16, UCP1) was observed between MVA and MSA nuclei.
Conclusions:
- The MA-INTACT mouse model provides a simple method for analyzing purified mature adipocyte nuclei.
- Isolated VAT and SAT adipocyte nuclei exhibit distinct transcriptomic patterns relevant to metabolic diseases.
- This model aids in studying the impact of lifestyle and therapeutics on obesity-related epigenomic health risks.

